30% off. Use code SUMMERSALE30 at checkout for 30% off for 12 months on Plus, Pro and Premium subscriptions. Subscribe now
United States Biotechnology & Medical Research

Odyssey Therapeutics Inc (ODTX)

Track

Over the last 90 days, Odyssey Therapeutics Inc. has seen significant insider buying activity, with a net buy value of over $75 million. Notable large buy transactions were made by TPG GP A, LLC and Li Nan (LN). The company's stock has experienced a 10% decrease in price over the same period.
Stock chart
Ticker: ODTX Exchange: NAS
Preparing chart...
Download chart Copy chart image Copy link Share to X Share


Subscribe to get access to the transaction volume chart and in-chart transaction details
• Purchase • Sale • Planned purchase • Planned sale Net purchase Net sale Activity signal Earnings
Top insiders
Trades
TPG GP A, LLC
1 purchase — total 25,000,002 USD
Buy 11 May 2026
Value US$4,334,747.53 | Price 135.61 | Shares 13,187
Buy 11 May 2026
Value US$2,001,056.61 | Price 135.54 | Shares 58,821
Sale 11 May 2026
Value US$450,690.89 | Price 93.36 | Shares 21,897
Buy 11 May 2026
Value US$2,399,994.00 | Price 18.00 | Shares 133,333
Sale 11 May 2026
Value US$4,986.00 | Price 18.00 | Shares 277
Buy 11 May 2026
Value US$3,999,996.00 | Price 18.00 | Shares 222,222
Sale 11 May 2026
Value US$19,170.00 | Price 18.00 | Shares 1,065
Buy 11 May 2026
Value US$19,999,998.00 | Price 18.00 | Shares 1,111,111
Buy 11 May 2026
Value US$199,998.00 | Price 18.00 | Shares 11,111
Buy 8 May 2026
Value US$19,999,998.00 | Price 18.00 | Shares 1,111,111
Buy 8 May 2026
Value US$100,000.00 | Price 20.00 | Shares 5,000
Buy 8 May 2026
Value US$20,000.00 | Price 20.00 | Shares 1,000
Abbreviations B: Buy, S: Sell, PP: Planned purchase, PlS: Planned sale, PrS: Proposed sale, O: Option / Other
Notification date Transaction date B/S Transaction type Insider and/or position Nb. shares
Price
Value 		Number of shares Price Value Details
2026-05-13 2026-05-11 B Purchase
3.2
TPG GP A, LLC
13,187 +46.5%
135.61
US$4,334,748 		13,187 +46.5% 135.61 US$4,334,748
2026-05-11 2026-05-11 B Purchase
2.8
SR ONE CAPITAL MANAGEMENT, LLC
Large shareholder
58,821 +24.8%
135.54
US$2,001,057 		58,821 +24.8% 135.54 US$2,001,057
2026-05-11 2026-05-11 S Sale
2.8
SR ONE CAPITAL MANAGEMENT, LLC
Large shareholder
21,897 -29.0%
93.36
US$450,691 		21,897 -29.0% 93.36 US$450,691
2026-05-11 2026-05-11 B Purchase
2.8
SR ONE CAPITAL MANAGEMENT, LLC
Large shareholder
133,333 +30.2%
18.00
US$2,399,994 		133,333 +30.2% 18.00 US$2,399,994
2026-05-11 2026-05-11 S Sale
2.8
SR ONE CAPITAL MANAGEMENT, LLC
Large shareholder
277 -0.1%
18.00
US$4,986 		277 -0.1% 18.00 US$4,986
2026-05-11 2026-05-11 B Purchase
2.8
SR ONE CAPITAL MANAGEMENT, LLC
Large shareholder
222,222 +13.8%
18.00
US$3,999,996 		222,222 +13.8% 18.00 US$3,999,996
2026-05-11 2026-05-11 S Sale
2.8
SR ONE CAPITAL MANAGEMENT, LLC
Large shareholder
1,065 -0.1%
18.00
US$19,170 		1,065 -0.1% 18.00 US$19,170
2026-05-11 2026-05-11 B Purchase
Li Nan (LN)
Non-Executive Director
1,111,111 +50.0%
18.00
US$19,999,998 		1,111,111 +50.0% 18.00 US$19,999,998
2026-05-11 2026-05-11 B Purchase
Chu Shelley
Non-Executive Director
11,111 +inf%
18.00
US$199,998 		11,111 +inf% 18.00 US$199,998
2026-05-12 2026-05-08 B Purchase
Dimension Capital II, L.P.
Non-Executive Director
1,111,111 +50.0%
18.00
US$19,999,998 		1,111,111 +50.0% 18.00 US$19,999,998
2026-05-11 2026-05-08 B Purchase
LEIDEN JEFFREY M
Non-Executive Director
5,000 +1.9%
20.00
US$100,000 		5,000 +1.9% 20.00 US$100,000
2026-05-11 2026-05-08 B Purchase
1.4
Haas Jason

Chief Financial Officer

Officer
1,000 +1.6%
20.00
US$20,000 		1,000 +1.6% 20.00 US$20,000
Explore more

More insider trading research around Odyssey Therapeutics Inc

More insider trades in United States
Similar Healthcare companies with insider activity
More Pharmaceuticals & Medical Research companies with insider activity
More Biotechnology & Medical Research companies with insider activity
Insider trading in North America